RecruitingNCT07101094
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Real-world Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Sponsor
Bristol-Myers Squibb
Enrollment
300 participants
Start Date
Sep 22, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to understand treatment preference and satisfaction among adults with schizophrenia in the United States who are prescribed xanomeline and trospium chloride (X/T) therapy
Eligibility
Min Age: 18 Years
Inclusion Criteria6
- Aged ≥18 years at index date.
- Have a confirmed diagnosis of schizophrenia before index date.
- Receipt of an initial prescription order for xanomeline and trospium chloride (XT) and plan to fill and initiate such therapy.
- Provide a signed and dated Institutional Review Board (IRB)/Independent Ethics Committee (IEC)-approved written informed consent form (ICF) in accordance with regulatory, local, and institutional guidelines.
- Agree to use an electronic device to record, or provide paper entry of, patient-reported outcomes (in English or Spanish).
- English or Spanish speaking.
Exclusion Criteria2
- Participation in an interventional study within the last 30 days or plan to participate in such study at the time of eligibility screening.
- Evidence of use of XT prior to time of eligibility screening.
Interventions
DRUGxanomeline and trospium chloride (X/T) therapy
According to the product label
Locations(17)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07101094
Related Trials
Tolerability of MDMA in Schizophrenia
NCT057703751 location
Cerebellar Modulation of Cognition in Psychosis
NCT061077642 locations
Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
NCT037940761 location
A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia
NCT0688278555 locations
Cerebellar Stimulation and Cognitive Control
NCT032171101 location